Research Labs

Molecular and cell biologist Christine Mayr studies how 3′UTRs regulate protein functions and how mRNAs contribute to cytoplasmic organization.

Physician-scientist Ingo Mellinghoff studies signal transduction alterations in primary brain tumors.

Luc Morris is a physician-scientist whose laboratory studies how tumor genetics influence the development of cancer, escape from immune surveillance, and immunotherapy outcomes in cancers of the head and neck and other sites.

Computational biologist Quaid Morris uses artificial intelligence techniques and develops machine learning algorithms to study gene regulation, cancer evolution, clinical informatics, and other topics in systems biology.

Cell biologist Philipp Niethammer investigates tissue damage responses with advanced imaging approaches in zebrafish.

Systems biologist Thomas Norman develops new computational and functional genomics approaches for studying how genes interact to realize complex phenotypes.

Cancer geneticist Kenneth Offit focuses on gene characterization; genetic and epidemiologic studies of cancer-predisposing alleles; and the therapeutic, prognostic, and psychosocial translation of these findings.

Led by Dr. Irene Orlow, the Molecular Epidemiology Laboratory participates in self-initiated research & supports investigations from the Population Sciences Research and Clinical Research programs that involve handling and testing of a variety of human specimens.

The Pavletich laboratory studies the structural biology of pathways that control cell growth and maintain the integrity of the genome.

Computational biologist Dana Pe’er combines single-cell and spatial profiling technologies with machine learning approaches to address fundamental questions in gene regulation, cellular plasticity and cell-cell communication in the contexts of cancer, immunity and development.